Alison Lawton

Alison Lawton

Director/Board Member presso DIANTHUS THERAPEUTICS, INC.

Patrimonio netto: 71 817 $ in data 31/03/2024

62 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Alison Francis Lawton is currently the Director at AgBiome INC, the Independent Director at X4 Pharmaceuticals, Inc., the Director at SwanBio Therapeutics, Inc., the Independent Director at Dianthus Therapeutics, Inc., the Independent Member-Supervisory Board at ProQR Therapeutics NV, and the President at Cadena Bio, Inc. Previously, she held positions such as Chairman & President at Regulatory Affairs Professionals Society, Independent Director at Cubist Pharmaceuticals LLC, Director at CoLucid Pharmaceuticals, Inc., Independent Director at Spyre Therapeutics, Inc., Director at Follica, Inc., Director at Massachusetts Medical Device Industry Council, Independent Director at Verastem, Inc., Director at Kaleido Biosciences, Inc., Director at Magenta Therapeutics, Inc., Senior Vice President at Genzyme Corp., Chief Operating Officer at Aura Biosciences, Inc., Principal at Parke-Davis & Co. Ltd., General Manager at Genzyme Biosurgery Corp., General Manager-Biosurgery at Sanofi, Inc., Chief Operating Officer at OvaScience, Inc., Head-Genzyme Biosurgery at Sanofi-Aventis, Inc., and Chief Operating Officer at X4 Pharmaceuticals, Inc. She completed her undergraduate degree at King's College London.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValorizzazioneData di valutazione
13/06/2023 51 667 ( 0.03% ) 71 817 $ 31/03/2024
31/12/2023 0 ( -.--% ) - $ 31/03/2024
11/09/2023 0 ( -.--% ) - $ 31/03/2024
24/10/2023 0 ( -.--% ) - $ 31/03/2024

Posizioni attive di Alison Lawton

SocietàPosizioneInizio
PROQR THERAPEUTICS N.V. Director/Board Member 17/09/2014
X4 PHARMACEUTICALS, INC. Director/Board Member 05/10/2020
DIANTHUS THERAPEUTICS, INC. Director/Board Member 11/09/2023
Director/Board Member 04/05/2021
Director/Board Member 19/01/2021
President -
Tutte le posizioni attive di Alison Lawton

Precedenti posizioni note di Alison Lawton

SocietàPosizioneFine
SPYRE THERAPEUTICS, INC. Director/Board Member 01/02/2024
KALEIDO BIOSCIENCES, INC. Chief Executive Officer 16/06/2020
VERASTEM, INC. Director/Board Member 19/05/2020
░░░░░░░ ░░░░░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Alison Lawton

Formazione di Alison Lawton

King's College London Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Alison Lawton

Relazioni

100 +

Relazioni di 1° grado

23

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa7
AURA BIOSCIENCES, INC.

Health Technology

SPYRE THERAPEUTICS, INC.

Health Technology

VERASTEM, INC.

Health Technology

PROQR THERAPEUTICS N.V.

Health Technology

KALEIDO BIOSCIENCES, INC.

Health Technology

X4 PHARMACEUTICALS, INC.

Health Technology

DIANTHUS THERAPEUTICS, INC.

Health Technology

Aziende private15

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Retail Trade

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Vedi le connessioni aziendali